Pfizer Cardiovascular & Metabolic Diseases

View the org chart displaying its 2 main executives

Most searched biographies at Pfizer Cardiovascular & Metabolic Diseases

• Morris Birnbaum, Chief Scientific Officer
• Kendra Bence, Senior Director, Metabolism

Create your alert
to follow the executive moves at Pfizer Cardiovascular & Metabolic Diseases.

Pfizer Cardiovascular & Metabolic Diseases has 2,281 competitors including Lonza (Switzerland), Eurofins (Luxembourg) and Adaptive Phage Therapeutics (United States (USA)).

Popular M&A news in Biotechnology

• Endeavor BioMedicines has just announced a $132 Million fundraising (posted on April 25 2024).
• Metsera has just announced a $290 Million fundraising (posted on April 23 2024).
• Histogen has filed for bankruptcy protection  (posted on April 19 2024).

Popular contacts in Biotechnology

• Ali Behbahani - Non-Executive Director at Adaptimmune Therapeutics
• Vik Bajaj - Director at Interline Therapeutics
• Khalil Barrage - Interim Chairman of the Board at Sensorion

Learn more about the Biotechnology industry >

Press releases by Pfizer Cardiovascular & Metabolic Diseases

Social media about Pfizer Cardiovascular & Metabolic Diseases

• Pfizer Cardiovascular & Metabolic Diseases on Wikipedia, Google News & Yahoo Finance
• Pfizer Cardiovascular & Metabolic Diseases on LinkedIn, Twitter & YouTube

Contact by email its executives including Morris Birnbaum

Call Pfizer Cardiovascular & Metabolic Diseases at +1 212...

View the org chart

Register to receive your alert

Report an error